Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Pharma stocks for some reason are coming out of a correction. I am not upbeat on pharma but at least for today, Cipla and Lupin are both buying opportunities. It is just intraday.""M&M Financial Services had a sharp correction and bounced back very nicely. It is a buying opportunity for the day or you can even carry it," he said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
